Goldman Sachs Call 240 TGT 19.07..../ DE000GG6GR06 /
2024-06-03 9:33:34 AM | Chg.0.000 | Bid9:55:08 PM | Ask9:55:08 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.001EUR | 0.00% | 0.002 Bid Size: 10,000 |
0.032 Ask Size: 5,000 |
Target Corp | 240.00 USD | 2024-07-19 | Call |
GlobeNewswire
10:10 PM
Applied Optoelectronics to Present at the Rosenblatt 4th Annual Technology Summit: The Age of AI
GlobeNewswire
10:10 PM
TEN Ltd. Announces Completion of Viken Fleet Acquisition and Sale of Aframax Tanker and LNG Carrier
GlobeNewswire
10:10 PM
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4...
GlobeNewswire
10:10 PM
Locafy to Participate in the “Charting the Course: Navigating the Intersection of TMT and Business i...
GlobeNewswire
10:07 PM
SPROUT SOCIAL 40 DAY NOTICE: Investors of Sprout Social, Inc. (Nasdaq: SPT) are Encouraged to Contac...
GlobeNewswire
10:05 PM
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
10:05 PM
Kernel Group Holdings, Inc. Extends Period to Consummate Initial Business Combination
GlobeNewswire
10:05 PM
FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate FibroG...
GlobeNewswire
10:05 PM
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
10:05 PM
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
GlobeNewswire
10:05 PM
SECURITIES FRAUD INVESTIGATION: Investors of CAE, Inc. (NYSE: CAE) Who Lost Money on Company Impairm...
GlobeNewswire
10:05 PM
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
10:05 PM
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Cli...
GlobeNewswire
10:05 PM
Safe Bulkers, Inc. Announces Agreement for the Acquisition of One Japanese Kamsarmax Class Dry-bulk ...
GlobeNewswire
10:04 PM
BIOGEN 50 DAY NOTICE: Investors of Biogen Inc. (Nasdaq: BIIB) are Encouraged to Contact BFA Law Befo...